What is the purpose of the prospective multicenter trial of robotically assisted totally endoscopic coronary artery bypass grafting?
The purpose of the prospective multicenter trial of robotically assisted totally endoscopic coronary artery bypass grafting was to evaluate the safety and efficacy of the totally endoscopic robotic approach in comparison to the conventional approach of coronary artery bypass grafting (CABG). The trial was conducted at multiple sites with a total of 66 patients who were randomized into two groups: one group underwent totally endoscopic robotic CABG surgery and the other underwent conventional CABG surgery. The primary outcome measure was the composite of death or major adverse cardiac and cerebrovascular events (MACCE) at 30 days postoperatively. Results showed that the overall 30-day composite outcome of mortality and MACCE was not significantly different between the two groups (2.3% in the robotic group vs. 3.0% in the conventional group, p=0.72). The results of the trial suggest that the totally endoscopic robotic approach is safe and effective in comparison to the traditional CABG surgery. 